Cooperative Agreement U18DP006906
Award Date 9/30/25
Completion Date 9/29/28
Dollars Obligated $350K
Funding Federal Agency
Awarding Federal Agency
Federal Grant Program
Assistance Type
Cooperative Agreement
Place of Performance
California, USA
Similar Awards
- This Cooperative Agreement award, valued at $492,348.00 and awarded by the National Center for Chronic Disease Prevention and Health Promotion, is part of the Cooperative Agreements for Diabetes Control Programs (CFDA 93.988). The award will support the University of Pittsburgh in implementing evidence-based lifestyle change interventions to improve health outcomes related to diabetes. The project aims to decrease type 2 diabetes risk, improve self-care practices, enhance diabetes care...
- This federal Cooperative Agreement award, valued at $350,000.00, is funded by the Centers for Disease Control and Prevention (CDC) under the Cooperative Agreements for Diabetes Control Programs (CFDA 93.988). The award, with a period of performance from September 30, 2025 to September 29, 2028, supports Clemson University in evaluating the Health Extension for Diabetes Program, a community-clinical linkage program. The objective of the project is to implement evidence-based strategies to...
- This federal Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC), under the Cooperative Agreements for Diabetes Control Programs (CFDA 93.988), provides $499,993.00 in funding to the University of Massachusetts Medical School (UMASS Medical) to implement research on lifestyle change interventions that address diabetes prevention and management. The award runs from September 30, 2025 to September 29, 2027. As an academic medical center and research institution,...
- This federal Cooperative Agreement award of $498,623.00, awarded on September 30, 2025 by the Centers for Disease Control and Prevention (CDC) under the Cooperative Agreements for Diabetes Control Programs (CFDA 93.988), supports the University of South Carolina in optimizing and projecting lifestyle behavioral interventions to sustain long-term health behaviors and outcomes in focus populations. The project aims to implement evidence-based strategies to decrease type 2 diabetes risk, improve...
- This Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the Cooperative Agreements for Diabetes Control Programs (CFDA 93.988) supports the establishment of a nationwide diabetes surveillance system for youth and young adults. The $500,000 award, with a performance period from September 30, 2025 to September 29, 2029, will fund research on the incidence, prevalence, risk factors, disparities, and social determinants of health related to diabetes in this...
- This $699,999 Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC), under the Cooperative Agreements for Diabetes Control Programs (CFDA 93.988), supports the NYU LANGONE HEALTH COORDINATING CENTER FOR CASSIDY (NYU COC) located in New York. The award, effective from September 30, 2025 to September 29, 2029, funds research, surveillance, community interventions, and health system improvements targeting priority populations experiencing diabetes-related health...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) awarded a $324,882 Project Grant under the Trans-NIH Research Support program (CFDA 93.310) to Kaiser Foundation Hospitals, doing business as Kaiser Permanente, to conduct a pilot trial of an intervention to support initial type 2 diabetes self-management among younger adults with children. The goal is to develop effective behavior change interventions that can improve early glycemic outcomes and influence...
- The federal Project Grant award of $731,071 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) aims to address the challenges preventing the provision of guideline-recommended diabetes care in the United States. The overarching goals are to: Describe differences in diabetes care receipt across individual, neighborhood, and insurance characteristics. Examine differences in...
- The Centers for Disease Control and Prevention (CDC) awarded a $499,971 Cooperative Agreement under the Cooperative Agreements for Diabetes Control Programs (CFDA 93.988) to the Ann & Robert H Lurie Children's Hospital of Chicago. The award, with a performance period from September 30, 2025 to September 29, 2029, will support the "Chicago Area Surveillance, Statistics, and Analysis Network for Diabetes, with Representative Ascertainment" project. This project aims to implement...
- The federal Project Grant award of $843,485 from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) will support Duke University's evaluation of two novel, population-tailored health insurance designs and their impact on diabetes outcomes among working-age adults. The project aims to assess 10-year trends in the adoption of population-tailored insurance plans that provide more generous benefits to...